 Efficacy will be assessed by determining the Topical Atopic Dermatitis Severity Index toADSI score, and the Visual Analogue Scale for Pruritis VAS score for both target areas at screening, predose on Day 1 of treatment and on Days 2, 7, 9, 12 and 15 of treatment. In addition, color pictures of the target areas will be taken predose on Day 1 of treatment and on Days 7 and 15 of treatment. Finally the Eczema Area and Severity Index EASI score will be determined for both target areas, predose on Day 1 of treatment and on Days 7 and 15 of treatment. 